Assertio Therapeutics Inc (ASRT) — Long-term Investment Intensity
Assertio Therapeutics Inc (ASRT) has a Long-term Investment Intensity of 0.1% as of December 2022. Long-term investments of $268.00K represent 0.1% of total assets of $413.91 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Assertio Therapeutics Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Assertio Therapeutics Inc Long-term Investment Intensity (2011–2022)
This chart shows how Assertio Therapeutics Inc's Long-term Investment Intensity has evolved across 9 annual periods from 2011 to 2022. As of December 2022, the intensity stands at 0.1%, reflecting long-term investments of $268.00K against total assets of $413.91 Million USD. For the complete balance sheet picture, see Assertio Therapeutics Inc total assets.
Annual Long-term Investment Intensity for Assertio Therapeutics Inc (2011–2022)
The table below presents the year-by-year Long-term Investment Intensity for Assertio Therapeutics Inc from 2011 to 2022, covering 9 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Assertio Therapeutics Inc (ASRT) financial obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 0.1% | $268.00K | $413.91 Million | ▼ -0.4 pp |
| 2021 | 0.5% | $1.58 Million | $326.55 Million | ▼ 0.0 pp |
| 2020 | 0.5% | $1.58 Million | $303.27 Million | ▼ -2.0 pp |
| 2019 | 2.5% | $13.06 Million | $527.17 Million | ▲ +1.2 pp |
| 2018 | 1.3% | $11.78 Million | $932.87 Million | ▲ +0.3 pp |
| 2014 | 1.0% | $6.96 Million | $711.07 Million | ▲ +0.2 pp |
| 2013 | 0.8% | $4.08 Million | $508.65 Million | ▼ -7.0 pp |
| 2012 | 7.8% | $11.08 Million | $141.65 Million | ▼ -24.8 pp |
| 2011 | 32.6% | $53.64 Million | $164.37 Million | — |